BridgeBio Pharma, Inc. (BBIO) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bridgebio Pharma, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.574 Good afternoon. I will be your conference operator today. 00:00:02.574 -- 00:00:06.998 All lines have been placed on mute to prevent any background noise. 00:00:06.998 -- 00:00:10.301 After the company's remarks, there will be a question and answer session. 00:00:10.301 -- 00:00:15.286 If you would like to ask a question, press star followed by the number one on your telephone 00:00:15.286 -- 00:00:20.632 keypad. If you'd like to withdraw your question, press star one a second time. 00:00:20.632 -- 00:00:24.936 Before we begin, I would like to remind everyone that today's call may contain forward-looking 00:00:24.936 -- 00:00:29.681 statements within the meaning of the federal securities laws, including, but not limited 00:00:29.681 -- 00:00:34.608 to, statements about BridgeBio's future operating and financial performance, business 00:00:34.608 -- 00:00:39.854 plans and prospects, and strategy. These statements are based on current expectations 00:00:39.854 -- 00:00:44.280 and assumptions that are subject to risks and uncertainties, which could cause actual 00:00:44.280 -- 00:00:48.404 results to differ materially from those expressed or implied in these forward-looking 00:00:48.404 -- 00:00:53.851 statements. For a discussion of these risks and uncertainties, please refer to the disclosure 00:00:53.851 -- 00:00:58.823 in today's earnings release and BridgeBio's periodic reports and SEC filings. 00:00:58.823 -- 00:01:03.989 All statements made here are based on information available to BridgeBio as of today, 00:01:03.989 -- 00:01:08.514 and the company undertakes no obligation to update any forward-looking statements made 00:01:08.514 -- 00:01:11.457 during this call, except as required by law. 00:01:11.457 -- 00:01:15.541 With th...